The primary objective of PATIENCE is to develop a standardized approach to the treatment of NTM in CF patients with a diagnosis of NTM disease. The secondary objectives are to: - Evaluate the feasibility and tolerability of a standardized treatment protocol for NTM disease - Evaluate effectiveness of a standardized NTM disease treatment protocol to serve as baseline/reference estimates of endpoints in clinical care and future therapeutic trials - Support biomarker development for markers of NTM treatment response through banking of clinical specimens and NTM isolates linked with outcomes data - Characterize clinical features of patients achieving treatment success compared to those unresponsive to treatment
The purpose of this study is to characterize nonprescription medication dispensing policies and procedures used by athletic trainers and determine the level of engagement between pharmacy staff and athletic trainers at Universities within the Atlantic Coast Conference.
The purpose of this research study is to better understand the challenges that breast cancer patients and providers face at Kamuzu Central Hospital. The study will explore what it's like for patients to go through breast cancer treatment and what it's like for breast cancer providers to recommend breast cancer treatment.
The purpose is to understand how many people are currently on leave from work, and how people feel about their current or most recent workplace.
This registry will collect data about pediatric patients with rare genetic diseases. This data and participating patients will enable current and future research aimed at better understanding, diagnosing, and treating patients affected by a wide range of genetic conditions.
This is a multicenter research study to evaluate the long-term safety and effectiveness of cochlear implantation in adults and children with single-sided deafness and asymmetric hearing loss. Approval for cochlear implantation for single-sided deafness and asymmetric hearing loss was recently obtained by MED-EL Corporation; the FDA requires a post-approval study examining the long-term effects of cochlear implantation in single-sided deafness and asymmetric hearing loss. Data from the University of North Carolina at Chapel Hill reporting on 37 clinical trial subjects with single-sided deafness and asymmetric hearing loss provided the bulk of the evidence used to support this approval. The present study design is a replication of that clinical trial protocol with only necessary modifications to construct a feasible post-approval study protocol. Data from this study has been published and demonstrate significant improvements in speech perception in noise, localization, and quality of life.
This study is partnering with communities to identify the best ways to provide COVID-19 testing and vaccines to people who have been disproportionately affected by COVID-19. This includes communities of color, essential workers, immigrants and migrants, people in rural areas, and people with chronic diseases like diabetes and high blood pressure. We want to train community outreach workers and peer recruiters from community and faith-based organizations to help reach these underserved populations with COVID-19 testing and COVID-19 vaccines - a strategy known as "community-based task shifting." Thus, we will be conducting focus groups and theater testing sessions and questionnaires with patients who have received COVID-19 health services and focus groups and interviews with key stakeholders and theater testing sessions and questionnaires with individuals who work in community outreach or peer health education organizations for COVID-19 health services.
We are investigating the effects of thinking about the universe on perceptions of meaning in life.
To determine how patients are doing who have received Zulresso treatment in the past 12 months.
To better understand what types of information resources that serious leisure maker type hobbyists use and how the resources they prefer change over a single research session through technology, such as the web.